Palmiflam

Palmiflam contains 300 mg of palmitoylethanolamide (PEA). PEA belongs to the family of N-acylethanolamines (NAEs), endogenous biologically active lipids14 (endogenously produced amide).

Clinical use

In India, PEA is approved as food for special medical purpose (FSMP). It is useful to improve chronic pain mainly neuropathic pain and joint pain.

Place of PEA therapy in neuropathic and chronic pain management

Use as add-on treatment to current the therapy.

References

  1. Gabrielsson L, Mattsson S, Fowler CJ. Palmitoylethanolamide for the treatment of pain: pharmacokinetics, safety and efficacy. Br J Clin Pharmacol. 2016 Oct;82(4):932-42. doi: 10.1111/bcp.13020.